<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2312-3893</journal-id>
<journal-title><![CDATA[Revista Virtual de la Sociedad Paraguaya de Medicina Interna]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. virtual Soc. Parag. Med. Int.]]></abbrev-journal-title>
<issn>2312-3893</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Paraguaya de Medicina Interna]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2312-38932025000100208</article-id>
<article-id pub-id-type="doi">10.18004/rvspmi/2312-3893/2025.e12122508</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Prevalencia de hipoglucemias inadvertidas en pacientes con diabetes de un hospital de referencia]]></article-title>
<article-title xml:lang="en"><![CDATA[Prevalence of inadvertent hypoglycemia in patients with diabetes in a referral hospital]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Soto Valiente]]></surname>
<given-names><![CDATA[Sandra María]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Altemburger Leguizamón]]></surname>
<given-names><![CDATA[Jorge Alejandro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vera Núñez]]></surname>
<given-names><![CDATA[María Liz]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cañete Amarilla]]></surname>
<given-names><![CDATA[Carlos Iván]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Central de Policía Rigoberto Caballero.  ]]></institution>
<addr-line><![CDATA[Asunción ]]></addr-line>
<country>Paraguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2025</year>
</pub-date>
<volume>12</volume>
<numero>1</numero>
<fpage>208</fpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_arttext&amp;pid=S2312-38932025000100208&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_abstract&amp;pid=S2312-38932025000100208&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_pdf&amp;pid=S2312-38932025000100208&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  la hipoglucemia inadvertida se define como la disminución de la capacidad de percibir los síntomas de hipoglucemia con valores de glucosa inferiores a 70 mg/dL. Uno de los métodos más utilizados para medir la percepción de hipoglucemia inadvertida es el cuestionario de Clarke.  Objetivo:  determinar la prevalencia de percepción de hipoglucemias inadvertidas en una cohorte de pacientes portadores de diabetes mellitus tipo 2, usuarios de insulina, que realicen sus controles en el Hospital Central de Policía Rigoberto Caballero, Asunción, Paraguay, durante el mes de junio de 2024.  Metodología: se realizó un estudio observacional, descriptivo, transversal, retrospectivo, con muestreo no probabilístico por conveniencia. La población accesible correspondió a pacientes de sexo masculino y femenino, mayores de 40 años, portadores de diabetes mellitus tipo 2, usuarios de insulina, que realizaban sus controles en el mencionado centro. El reclutamiento de datos fue realizado a partir de un cuestionario desarrollado por los autores, el cual incluye el cuestionario de Clarke y otras variables de interés.  Resultados:  entre los 42 pacientes estudiados, 7 (16,6%) presentaron hipoglucemias inadvertidas basados en el cuestionario de Clarke. El 85,7% de los pacientes afirman siempre tener síntomas cuando se constata hipoglucemias. La edad media fue de 62 ± 11 años. El 54,76% era de sexo masculino y 54,76% eran procedentes del Departamento Central. Los tipos de insulina fueron: glargina U300 35 pacientes (83,33%), detemir 2 pacientes (4,76%) y NPH 5 pacientes (11,90).  Conclusión:  la prevalencia de percepción de hipoglucemias inadvertidas determinadas mediante el cuestionario de Clarke en pacientes portadores de diabetes mellitus tipo 2 fue del 16,66%.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  Inadvertent hypoglycemia is defined as a decreased ability to perceive symptoms of hypoglycemia with glucose values below 70 mg/dL. One of the most widely used methods to measure the perception of inadvertent hypoglycemia is the Clarke questionnaire.  Objective:  To determine the prevalence of perception of inadvertent hypoglycemia in a cohort of patients with type 2 diabetes mellitus, insulin users, who undergo check-ups at the Central Police Hospital Rigoberto Caballero, Asuncion, Paraguay, during June 2024.  Methodology:  An observational, descriptive, cross-sectional, retrospective, non-probabilistic convenience sampling study was carried out. The accessible population corresponded to male and female patients over 40 years of age, carriers of type 2 diabetes mellitus, insulin users, who underwent check-ups at the aforementioned center. Data recruitment was carried out using a questionnaire developed by the authors, which includes the Clarke questionnaire and other variables of interest.  Results:  among the 42 patients studied, 7 (16.6%) presented inadvertent hypoglycemia based on Clarke questionnaire. A total of 85.7% of the patients affirmed that they were hypoglycemic, and 85.7% of the patients reported always having symptoms when hypoglycemia was detected. The mean age was 62 ± 11 years, 54.76% were male, and 54.76% were from the Central Department. The types of insulin used were: U300 glargine 35 patients (83.33%), detemir 2 patients (4.76%), and NPH 5 patients (11.90%).  Conclusion:  The prevalence of perception of inadvertent hypoglycemia determined by Clarke's questionnaire in patients with type 2 diabetes mellitus was 16.66%.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[diabetes mellitus]]></kwd>
<kwd lng="es"><![CDATA[hipoglucemia]]></kwd>
<kwd lng="es"><![CDATA[insulinas]]></kwd>
<kwd lng="es"><![CDATA[encuestas y cuestionarios]]></kwd>
<kwd lng="es"><![CDATA[prevalencia]]></kwd>
<kwd lng="en"><![CDATA[diabetes mellitus]]></kwd>
<kwd lng="en"><![CDATA[hypoglycemia]]></kwd>
<kwd lng="en"><![CDATA[insulins]]></kwd>
<kwd lng="en"><![CDATA[surveys and questionnaires]]></kwd>
<kwd lng="en"><![CDATA[prevalence.]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<collab>Organización Panamericana de la Salud-OPS</collab>
<collab>Organización Mundial de la Salud-OMS</collab>
<source><![CDATA[Diabetes]]></source>
<year>2023</year>
<publisher-name><![CDATA[OPS/OMS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aschner]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Muñoz Velandía]]></surname>
<given-names><![CDATA[OM]]></given-names>
</name>
<name>
<surname><![CDATA[Girón]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[OM]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Casas]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
</person-group>
<source><![CDATA[Guía de práctica clínica para el diagnóstico, tratamiento y seguimiento de la diabetes mellitus tipo 2 en la población mayor de 18 años]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Bogotá ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud Pública y Bienestar Social</collab>
<collab>Programa Nacional de Diabetes</collab>
<source><![CDATA[Flujogramas]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Asunción ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Salud Pública y Bienestar Social, Programa Nacional de Diabetes]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Henao-Carrillo]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez Medina]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[García-Cajiao]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Robledo Gómez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Mejía Piña]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Chahin Padilla]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Asociación entre el puntaje del cuestionario de Clarke y las métricas aportadas por el monitoreo continuo de glucosa en pacientes con diabetes y alto riesgo de hipoglucemia]]></article-title>
<source><![CDATA[Rev Colomb Endocrinol Diabet Metab]]></source>
<year>2023</year>
<volume>10</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pinés Corrales]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Arias Lozano]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez Martínez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[López Jiménez]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Sirvent Segovia]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[García Blasco]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de hipoglucemia grave en una cohorte de pacientes con diabetes tipo 1]]></article-title>
<source><![CDATA[Endocrinol Diabetes Nutr]]></source>
<year>2021</year>
<volume>68</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>47-52</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jansa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Quirós]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Giménez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Vidal]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Galindo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Conget]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Análisis psicométrico de las versiones en lengua castellana y catalana de un cuestionario de percepción de la hipoglucemia]]></article-title>
<source><![CDATA[Med Clin (Barc)]]></source>
<year>2015</year>
<volume>144</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>440-4</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Clarke]]></surname>
<given-names><![CDATA[WL]]></given-names>
</name>
<name>
<surname><![CDATA[Cox]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Gonder-Frederick]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Julian]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Schlundt]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Polonsky]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>1995</year>
<volume>18</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>517-22</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Satue]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Tenorio-Salgueiro]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Montoto]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Guisado Barral]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Miriam]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<collab>Congreso SEFAC</collab>
<source><![CDATA[Proyecto DI-NES]]></source>
<year>2022</year>
<publisher-loc><![CDATA[Aragón ]]></publisher-loc>
<publisher-name><![CDATA[Sociedad Española de Farmacia Familiar y Comunitaria]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vidal]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Jansà]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Roca]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Yoldi]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Cardona-Hernández]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Giménez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Conget]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hipoglucemia desapercibida en jóvenes con diabetes tipo 1 trasladados a un centro de adultos]]></article-title>
<source><![CDATA[Endocrinol Diabetes Nutr]]></source>
<year>2020</year>
<volume>67</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>394-400</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Costa Gil]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Linari]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Pugnaloni]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Zambon]]></surname>
<given-names><![CDATA[FG]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez Manghi]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Rezzónico]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hipoglucemia en pacientes con diabetes tipo 1 y tipo 2 en tratamiento con insulina. Resultados del estudio HAT en Argentina]]></article-title>
<source><![CDATA[Medicina]]></source>
<year>2017</year>
<volume>77</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>449-57</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aparicio Montes]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<source><![CDATA[Incidencia de hipoglucemia inadvertida en pacientes geriátricos con diabetes mellitus tipo 2 en tratamiento que fueron atendidos en el servicio de urgencias del HGZ No]]></source>
<year>2024</year>
<publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Autónoma de San Luis Potosí, Facultad de Medicina]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cerda Martínez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Hipoglucemias inadvertidas. Detección desde un servicio de urgencias hospitalario]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Valencia ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Católica de Valencia &#8220;San Vicente Mártir&#8221;]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gumprecht]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Nabrdalik]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hypoglycemia in patients with insulin&#8209;treated diabetes]]></article-title>
<source><![CDATA[Pol Arch Med Wewn]]></source>
<year>2016</year>
<volume>126</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>870-8</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Frier]]></surname>
<given-names><![CDATA[BM]]></given-names>
</name>
<name>
<surname><![CDATA[Ratzki-Leewing]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Harris]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reporting of hypoglycaemia in clinical trials of basal insulins]]></article-title>
<source><![CDATA[Diabetes Obes Metab]]></source>
<year>2019</year>
<volume>21</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1529-42</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Goh]]></surname>
<given-names><![CDATA[SY]]></given-names>
</name>
<name>
<surname><![CDATA[Hussein]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Rudijanto]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Review of insulin-associated hypoglycemia and its impact on the management of diabetes in Southeast Asian countries]]></article-title>
<source><![CDATA[J Diabetes Investig]]></source>
<year>2017</year>
<volume>8</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>635-45</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Blonde]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Bailey]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Sullivan]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Freemantle]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Insulin glargine 300 units/mL for the treatment of individuals with type 2 diabetes in the real world]]></article-title>
<source><![CDATA[Diabetes Obes Metab]]></source>
<year>2021</year>
<volume>23</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1713-21</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<collab>Canadian Diabetes Association</collab>
<collab>Clinical Practice Guidelines Expert Committee</collab>
<article-title xml:lang=""><![CDATA[Hypoglycemia]]></article-title>
<source><![CDATA[Can J Diabetes]]></source>
<year>2013</year>
<volume>37</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>S69-71</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Danne]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Bangstad]]></surname>
<given-names><![CDATA[HJ]]></given-names>
</name>
<name>
<surname><![CDATA[Deeb]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Jarosz-Chobot]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Mungaie]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Saboo]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<collab>International Society for Pediatric and Adolescent Diabetes</collab>
<article-title xml:lang=""><![CDATA[ISPAD Clinical Practice Consensus Guidelines 2014]]></article-title>
<source><![CDATA[Pediatr Diabetes]]></source>
<year>2014</year>
<volume>15</volume>
<numero>^s20</numero>
<issue>^s20</issue>
<supplement>20</supplement>
<page-range>115-34</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Avila-Fematt]]></surname>
<given-names><![CDATA[FMG]]></given-names>
</name>
<name>
<surname><![CDATA[Montaña-Alvarez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hipoglucemia en el anciano con diabetes mellitus]]></article-title>
<source><![CDATA[Rev Invest Clin]]></source>
<year>2010</year>
<volume>62</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>366-74</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barrios]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bueno]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Benítez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Alsina]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Asociación entre hipoglucemia y morbi-mortalidad en pacientes hospitalizados con diabetes tipo 2]]></article-title>
<source><![CDATA[Mem. Inst. Investig. Cienc. Salud]]></source>
<year>2017</year>
<volume>15</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>13-8</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
